Data from: Comparison of T2*-weighted and QSM contrasts in Parkinson's disease to visualize the STN with MRI

  • Anneke Alkemade (Contributor)
  • Gilles de Hollander (Contributor)
  • Max C. Keuken (Contributor)
  • Andreas Schäfer (Contributor)
  • Derek V. M. Ott (Contributor)
  • David Weise (Contributor)
  • Sonja Kotz (Contributor)
  • Birte U. Forstmann (Contributor)



The subthalamic nucleus (STN) plays a crucial role in the surgical treatment of Parkinson's disease (PD). Studies investigating optimal protocols for STN visualization using state of the art magnetic resonance imaging (MRI) techniques have shown that susceptibility weighted images, which display the magnetic susceptibility distribution, yield better results than T1-weighted, T2-weighted, and T2*-weighted contrasts. However, these findings are based on young healthy individuals, and require validation in elderly individuals and persons suffering from PD. Using 7T MRI, the present study set out to investigate which MRI contrasts yielded the best results for STN visualization in 12 PD patients and age-matched healthy controls (HC). We found that STNs were more difficult to delineate in PD as reflected by a lower inter-rater agreement when compared to HCs. No STN size differences were observed between the groups. Analyses of quantitative susceptibility mapping (QSM) images showed a higher inter-rater agreement reflected by increased Dice-coefficients. The location of the center of mass of the STN was not affected by contrast. Overall, contrast-to-noise ratios (CNR) were higher in QSM than in T2*-weighted images. This can at least partially, explain the higher inter-rater agreement in QSM. The current results indicate that the calculation of QSM contrasts contributes to an improved visualization of the entire STN. We conclude that QSM contrast is the preferred choice for the visualization of the STN in persons with PD as well as in aging HC.,STN probability atlasThis atlas takes advantage of ultra-high resolution 7T MRI to provide unprecedented levels of detail on structures of the basal ganglia in-vivo. The atlas includes a disease-specific probability map of the subthalamic Nucleus based on Parkinson's Disease patients. The atlas is based either on QSM or T2*-weighted structural,

Terms of reuse

Date made available1 Apr 2017

Cite this